Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH4 | P08319 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 5/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.38 |
| ▸ | GAPDH | P04406 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10383718 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14093766 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL93171 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2111102 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2109688 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2110531 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL8810975 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2108219 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14093584 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL10383121 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| CN-114410481-B | Trichoderma asperellum and application thereof | 广州市土根旺生物科技有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-112209967-A | Chiral spiro monophosphine-oxazoline ligand and preparation method thereof | 瑞博(杭州)医药科技有限公司 | 2021-01-12 | — | — | CN | claimed |
| CN-111909206-A | Chiral spiro monophosphine ligand and preparation method thereof | 浙江瑞博制药有限公司 | 2020-11-10 | — | — | CN | claimed |
| US-9580636-B2 | Secondary esters, methods of making, and uses thereof | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-02-28 | — | — | US | claimed |
| US-20160319178-A1 | Secondary Esters, Methods of Making, and Uses Thereof | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2016-11-03 | — | — | US | claimed |
| WO-2016176243-A1 | SECONDARY ESTERS, METHODS OF MAKING, AND USES THEREOF | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2016-11-03 | — | — | WO | claimed |
| EP-1680076-B1 | PHARMACEUTICAL AND COSMETIC FORMULATIONS FOR TREATING FINGERNAILS | BIOEQUAL AG (CH) | 2008-07-02 | — | — | EP | claimed |
| EP-0212838-B1 | OPTICALLY ACTIVE LIQUID CRYSTAL COMPOUND HAVING METHYLENEOXY GROUP AND COMPOSITION CONTAINING SAME | Chisso Corporation (JP) | 1990-10-03 | — | — | EP | claimed |
| US-4729847-A | LIGHT SWITCHING ELEMENT | CHISSO CORPORATION (JP) | 1988-03-08 | — | — | US | claimed |
| EP-0212838-A1 | Optically active liquid crystal compound having methyleneoxy group and composition containing same | Chisso Corporation (JP) | 1987-03-04 | — | — | EP | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | disclosed |
| US-20250049660-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2025-02-13 | — | — | US | disclosed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | disclosed |
| EP-0329153-A2 | Novel lactic acid derivatives and liquid crystal compositions containing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1989-08-23 | — | — | EP | disclosed |
| EP-0087679-B1 | 1,3-DIOXANES | MERCK PATENT GmbH (DE) | 1988-06-22 | — | — | EP | disclosed |
| US-4720558-A | Process for inverting the configuration of secondary alcohols | BAYER AKTIENGESELLSCHAFT (DE) | 1988-01-19 | — | — | US | disclosed |
| EP-0087679-A2 | 1,3-Dioxanes | MERCK PATENT GmbH (DE) | 1983-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049660-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | ADH1B 153/4885ADH1C 13/4885ADH1A 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.